Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Urology Reports
Published in: Current Urology Reports 3/2013

01-06-2013 | Prostate Cancer (D Parekh, Section Editor)

Does Robotic Prostatectomy Meet Its Promise in the Management of Prostate Cancer?

Authors: Kuo-How Huang, Stacey C. Carter, Jim C. Hu

Published in: Current Urology Reports | Issue 3/2013

Login to get access

Abstract

Following Walsh’s advances in pelvic anatomy and surgical technique to minimize intraoperative peri-prostatic trauma more than 30 years ago, open retropubic radical prostatectomy (RRP) evolved to become the gold standard treatment of localized prostate cancer, with excellent long-term survival outcomes [1•]. However, RRP is performed with great heterogeneity, even among high volume surgeons, and subtle differences in surgical technique result in clinically significant differences in recovery of urinary and sexual function. Since the initial description of robotic-assisted radical prostatectomy (RARP) in 2000 [2], and U.S. Food and Drug Administration approval shortly thereafter, RARP has been rapidly adopted and has overtaken RRP as the most popular surgical approach in the management of prostate cancer in the United States [3]. However, the surgical management of prostate cancer remains controversial. This is confounded by the idolatry of new technologies and aggressive marketing versus conservatism in embracing tradition. Herein, we review the literature to compare RRP to RARP in terms of perioperative, oncologic, and quality-of-life outcomes as well as healthcare costs. This is a particularly relevant, given the absence of randomized trials and long-term (more than 10-year) follow-up for RARP biochemical recurrence-free survival.
Literature
1.
• Walsh PC. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol. 1998;160(6 Pt 2):2418–24.PubMed
2.
Abbou CC, Hoznek A, Salomon L, et al. Remote laparoscopic radical prostatectomy carried out with a robot. Report of a case. Prog Urol. 2000;10(4):520–3.PubMed
3.
Yu HY, Hevelone ND, Lipsitz SR, Kowalczyk KJ, Hu JC. Use, costs and comparative effectiveness of robotic assisted, laparoscopic and open urological surgery. J Urol. 2012;187(4):1392–8.PubMedCrossRef
4.
Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273(7):548–52.PubMedCrossRef
5.
Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol. 2004;22(11):2141–9.PubMedCrossRef
6.
Schroder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012;366(11):981–90.PubMedCrossRef
7.
Andriole GL, Crawford ED, Grubb 3rd RL, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310–9.PubMedCrossRef
8.
Chou R, Lefevre ML. Prostate cancer screening–the evidence, the recommendations, and the clinical implications. JAMA. 2011;306(24):2721–2.PubMedCrossRef
9.
Crawford ED, Grubb III R, Black A, et al. Comorbidity and mortality results from a randomized prostate cancer screening trial. J Clin Oncol. 2011;29(4):355–61.PubMedCrossRef
10.
Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Eng J Med. 2009;360(13):1320–8.CrossRef
11.
Schroder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of follow-up. N Eng J Med. 2012;366(11):981–90.CrossRef
12.
Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Eng J Med. 2011;364(18):1708–17.CrossRef
13.
Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Eng J Med. 2012;367(3):203–13.CrossRef
14.
• Thompson Jr IM, Tangen CM. Prostate cancer–uncertainty and a way forward. N Eng J Med. 2012;367(3):270–1.CrossRef
15.
• Novara G, Ficarra V, Rosen RC, et al. Systematic Review and Meta-analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Prostatectomy. Eur Urol. 2012;62(3):431–52.PubMedCrossRef
16.
Tewari A, Sooriakumaran P, Bloch DA, Seshadri-Kreaden U, Hebert AE, Wiklund P. Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol. 2012;62(1):1–15.PubMedCrossRef
17.
Carlsson S, Adolfsson J, Bratt O, et al. Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden. Scand J Urol Nephrol. 2009;43(5):350–6.PubMedCrossRef
18.
Gilbert SM, Dunn RL, Miller DC, Daignault S, Ye Z, Hollenbeck BK. Mortality after urologic cancer surgery: impact of non-index case volume. Urology. 2008;71(5):906–10.PubMedCrossRef
19.
Barocas DA, Salem S, Kordan Y, et al. Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate cancer: comparison of short-term biochemical recurrence-free survival. J Urol. 2010;183(3):990–6.PubMedCrossRef
20.
Bhandari A, Mcintire L, Kaul SA, Hemal AK, Peabody JO, Menon M. Perioperative complications of robotic radical prostatectomy after the learning curve. J Urol. 2005;174(3):915–8.PubMedCrossRef
21.
Coelho RF, Palmer KJ, Rocco B, et al. Early complication rates in a single-surgeon series of 2500 robotic-assisted radical prostatectomies: report applying a standardized grading system. Eur Urol. 2010;57(6):945–52.PubMedCrossRef
22.
Lasser MS, Renzulli 2nd J, Turini 3rd GA, Haleblian G, Sax HC, Pareek G. An unbiased prospective report of perioperative complications of robot-assisted laparoscopic radical prostatectomy. Urology. 2010;75(5):1083–9.PubMedCrossRef
23.
Patel VR, Palmer KJ, Coughlin G, Samavedi S. Robot-assisted laparoscopic radical prostatectomy: perioperative outcomes of 1500 cases. J Endourol. 2008;22(10):2299–305.PubMedCrossRef
24.
Lepor H, Kaci L. Contemporary evaluation of operative parameters and complications related to open radical retropubic prostatectomy. Urology. 2003;62(4):702–6.PubMedCrossRef
25.
Mohamad BA, Marszalek M, Brossner C, et al. Radical prostatectomy in Austria: a nationwide analysis of 16,524 cases. Eur Urol. 2007;51(3):684–8. discussion 689.PubMedCrossRef
26.
• Optenberg SA, Wojcik BE, Thompson IM. Morbidity and mortality following radical prostatectomy: a national analysis of Civilian Health and Medical Program of the Uniformed Services beneficiaries. J Urol. 1995;153(6):1870–2.PubMedCrossRef
27.
Kowalczyk KJ, Levy JM, Caplan CF, et al. Temporal national trends of minimally invasive and retropubic radical prostatectomy outcomes from 2003 to 2007: results from the 100 % Medicare sample. Eur Urol. 2012;61(4):803–9.PubMedCrossRef
28.
Bolenz C, Gupta A, Hotze T, et al. Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer. Eur Urol. 2010;57(3):453–8.PubMedCrossRef
29.
Di Pierro GB, Baumeister P, Stucki P, Beatrice J, Danuser H, Mattei A. A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre with a limited caseload. Eur Urol. 2011;59(1):1–6.PubMedCrossRef
30.
Ficarra V, Novara G, Fracalanza S, et al. A prospective, non-randomized trial comparing robot-assisted laparoscopic and retropubic radical prostatectomy in one European institution. BJU Int. 2009;104(4):534–9.PubMedCrossRef
31.
Krambeck AE, Dimarco DS, Rangel LJ, et al. Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques. BJU Int. 2009;103(4):448–53.PubMedCrossRef
32.
Rocco B, Matei DV, Melegari S, et al. Robotic vs open prostatectomy in a laparoscopically naive centre: a matched-pair analysis. BJU Int. 2009;104(7):991–5.PubMedCrossRef
33.
Bolenz C, Freedland SJ, Hollenbeck BK, et al. Costs of Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol. In press.
34.
Carlsson S, Nilsson AE, Schumacher MC, et al. Surgery-related complications in 1253 robot-assisted and 485 open retropubic radical prostatectomies at the Karolinska University Hospital. Sweden Urology. 2010;75(5):1092–7.CrossRef
35.
•• Hu JC, Wang Q, Pashos CL, Lipsitz SR, Keating NL. Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol. 2008;26(14):2278–84.PubMedCrossRef
36.
Hu JC, Gu X, Lipsitz SR, et al. Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA. 2009;302(14):1557–64.PubMedCrossRef
37.
Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int. 2010;106(11):1734–8.PubMedCrossRef
38.
Trinh QD, Sammon J, Sun M, et al. Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample. Eur Urol. 2012;61(4):679–85.PubMedCrossRef
39.
Gainsburg DM, Wax D, Reich DL, Carlucci JR, Samadi DB. Intraoperative management of robotic-assisted versus open radical prostatectomy. Jsls. 2010;14(1):1–5.PubMedCrossRef
40.
Kordan Y, Barocas DA, Altamar HO, et al. Comparison of transfusion requirements between open and robotic-assisted laparoscopic radical prostatectomy. BJU Int. 2010;106(7):1036–40.PubMedCrossRef
41.
Finkelstein J, Eckersberger E, Sadri H, Taneja SS, Lepor H, Djavan B. Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience. Rev Urol. 2010;12(1):35–43.PubMed
42.
Tewari A, Srivasatava A, Menon M. A prospective comparison of radical retropubic and robot-assisted prostatectomy: experience in one institution. BJU Int. 2003;92(3):205–10.PubMedCrossRef
43.
Yuh BE, Nazmy M, Ruel NH, et al. Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy. Eur Urol. 2012;62(5):806–13.PubMedCrossRef
44.
Farnham SB, Webster TM, Herrell SD, Smith Jr JA. Intraoperative blood loss and transfusion requirements for robotic-assisted radical prostatectomy versus radical retropubic prostatectomy. Urology. 2006;67(2):360–3.PubMedCrossRef
45.
Nilsson AE, Carlsson S, Laven BA, Wiklund NP. Karolinska prostatectomy: a robot-assisted laparoscopic radical prostatectomy technique. Scand J Urol Nephrol. 2006;40(6):453–8.PubMedCrossRef
46.
Nelson B, Kaufman M, Broughton G, et al. Comparison of length of hospital stay between radical retropubic prostatectomy and robotic assisted laparoscopic prostatectomy. J Urol. 2007;177(3):929–31.PubMedCrossRef
47.
Menon M, Shrivastava A, Tewari A, et al. Laparoscopic and robot assisted radical prostatectomy: establishment of a structured program and preliminary analysis of outcomes. J Urol. 2002;168(3):945–9.PubMedCrossRef
48.
Stattin P, Holmberg E, Johansson JE, Holmberg L, Adolfsson J, Hugosson J. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst. 2010;102(13):950–8.PubMedCrossRef
49.
Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281(17):1591–7.PubMedCrossRef
50.
Choi WW, Gu X, Lipsitz SR, D'amico AV, Williams SB, Hu JC. The effect of minimally invasive and open radical prostatectomy surgeon volume. Urol Oncol. 2012;30(5):569–76.PubMedCrossRef
51.
• Masterson TA, Cheng L, Boris RS, Koch MO. Open vs. robotic-assisted radical prostatectomy: A single surgeon and pathologist comparison of pathologic and oncologic outcomes. Urol Oncol. In press.
52.
Novara G, Ficarra V, Mocellin S, et al. Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radical Prostatectomy. Eur Urol. 2012;62(3):382–404.PubMedCrossRef
53.
Ficarra V, Novara G, Artibani W, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2009;55(5):1037–63.PubMedCrossRef
54.
Menon M, Bhandari M, Gupta N, et al. Biochemical recurrence following robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up. Eur Urol. 2010;58(6):838–46.PubMedCrossRef
55.
Lowrance WT, Elkin EB, Jacks LM, et al. Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes. J Urol. 2010;183(4):1366–72.PubMedCrossRef
56.
Chino J, Schroeck FR, Sun L, et al. Robot-assisted laparoscopic prostatectomy is not associated with early postoperative radiation therapy. BJU Int. 2009;104(10):1496–500.PubMedCrossRef
57.
Penson DF. The effect of erectile dysfunction on quality of life following treatment for localized prostate cancer. Rev Urol. 2001;3(3):113–9.PubMed
58.
Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250–61.PubMedCrossRef
59.
Shikanov S, Desai V, Razmaria A, Zagaja GP, Shalhav AL. Robotic radical prostatectomy for elderly patients: probability of achieving continence and potency 1 year after surgery. J Urol. 2010;183(5):1803–7.PubMedCrossRef
60.
Novara G, Ficarra V, D'elia C, et al. Preoperative criteria to select patients for bilateral nerve-sparing robotic-assisted radical prostatectomy. J Sex Med. 2010;7(2 Pt 1):839–45.PubMedCrossRef
61.
Chauhan S, Coelho RF, Rocco B, Palmer KJ, Orvieto MA, Patel VR. Techniques of nerve-sparing and potency outcomes following robot-assisted laparoscopic prostatectomy. Int Braz J Urol. 2010;36(3):259–72.PubMedCrossRef
62.
Shikanov SA, Zorn KC, Zagaja GP, Shalhav AL. Trifecta outcomes after robotic-assisted laparoscopic prostatectomy. Urology. 2009;74(3):619–23.PubMedCrossRef
63.
Ficarra V, Novara G, Ahlering TE, et al. Systematic Review and Meta-analysis of Studies Reporting Potency Rates After Robot-assisted Radical Prostatectomy. Eur Urol. 2012;62(3):418–30.PubMedCrossRef
64.
Salonia A, Burnett AL, Graefen M, et al. Prevention and management of postprostatectomy sexual dysfunctions part 1: choosing the right patient at the right time for the right surgery. Eur Urol. 2012;62(2):261–72.PubMedCrossRef
65.
Kim SC, Song C, Kim W, et al. Factors determining functional outcomes after radical prostatectomy: robot-assisted versus retropubic. Eur Urol. 2011;60(3):413–9.PubMedCrossRef
66.
Coelho RF, Rocco B, Patel MB, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. J Endourol. 2010;24(12):2003–15.PubMedCrossRef
67.
Catalona WJ, Carvalhal GF, Mager DE, Smith DS. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol. 1999;162(2):433–8.PubMedCrossRef
68.
Lepor H, Nieder AM, Ferrandino MN. Intraoperative and postoperative complications of radical retropubic prostatectomy in a consecutive series of 1,000 cases. J Urol. 2001;166(5):1729–33.PubMedCrossRef
69.
Steiner MS, Morton RA, Walsh PC. Impact of anatomical radical prostatectomy on urinary continence. J Urol. 1991;145(3):512–4. discussion 514–515.PubMed
70.
Wiltz AL, Shikanov S, Eggener SE, et al. Robotic radical prostatectomy in overweight and obese patients: oncological and validated-functional outcomes. Urology. 2009;73(2):316–22.PubMedCrossRef
71.
Lei Y, Alemozaffar M, Williams SB, et al. Athermal division and selective suture ligation of the dorsal vein complex during robot-assisted laparoscopic radical prostatectomy: description of technique and outcomes. Eur Urol. 2011;59(2):235–43.PubMedCrossRef
72.
Coelho RF, Chauhan S, Orvieto MA, et al. Influence of modified posterior reconstruction of the rhabdosphincter on early recovery of continence and anastomotic leakage rates after robot-assisted radical prostatectomy. Eur Urol. 2011;59(1):72–80.PubMedCrossRef
73.
Freire MP, Weinberg AC, Lei Y, et al. Anatomic bladder neck preservation during robotic-assisted laparoscopic radical prostatectomy: description of technique and outcomes. Eur Urol. 2009;56(6):972–80.PubMedCrossRef
74.
Kowalczyk KJ, Huang AC, Hevelone ND, et al. Stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: technique and outcomes. Eur Urol. 2011;60(3):536–47.PubMedCrossRef
75.
Ficarra V, Novara G, Rosen RC, et al. Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy. Eur Urol. 2012;62(3):405–17.PubMedCrossRef
76.
Cappelleri JC, Siegel RL, Glasser DB, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile dysfunction and the sexual health inventory for men. Clin Ther. 2001;23(10):1707–19.PubMedCrossRef
77.
Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36(7):1002–12.PubMedCrossRef
78.
Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899–905.PubMedCrossRef
79.
Ficarra V, Sooriakumaran P, Novara G, et al. Systematic review of methods for reporting combined outcomes after radical prostatectomy and proposal of a novel system: the survival, continence, and potency (SCP) classification. Eur Urol. 2012;61(3):541–8.PubMedCrossRef
80.
Novara G, Ficarra V, D'elia C, Secco S, Cavalleri S, Artibani W. Trifecta outcomes after robot-assisted laparoscopic radical prostatectomy. BJU Int. 2011;107(1):100–4.PubMedCrossRef
81.
• Malcolm JB, Fabrizio MD, Barone BB, et al. Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer. J Urol. 2010;183(5):1822–8.PubMedCrossRef
82.
• Miller J, Smith A, Kouba E, Wallen E, Pruthi RS. Prospective evaluation of short-term impact and recovery of health related quality of life in men undergoing robotic assisted laparoscopic radical prostatectomy versus open radical prostatectomy. J Urol. 2007;178(3 Pt 1):854–8. discussion 859.PubMedCrossRef
83.
Hohwu L, Akre O, Pedersen KV, Jonsson M, Nielsen CV, Gustafsson O. Open retropubic prostatectomy versus robot-assisted laparoscopic prostatectomy: a comparison of length of sick leave. Scand J Urol Nephrol. 2009;43(4):259–64.PubMedCrossRef
84.
Lotan Y, Cadeddu JA, Gettman MT. The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniques. J Urol. 2004;172(4 Pt 1):1431–5.PubMedCrossRef
85.
Wilson T, Torrey R. Open versus robotic-assisted radical prostatectomy: which is better? Curr Opin Urol. 2011;21(3):200–5.PubMedCrossRef
86.
Scales Jr CD, Jones PJ, Eisenstein EL, Preminger GM, Albala DM. Local cost structures and the economics of robot assisted radical prostatectomy. J Urol. 2005;174(6):2323–9.PubMedCrossRef
87.
Smith Jr JA, Chan RC, Chang SS, et al. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. J Urol. 2007;178(6):2385–9. discussion 2389–2390.PubMedCrossRef
88.
Patel HR, Linares A, Joseph JV. Robotic and laparoscopic surgery: cost and training. Surg Oncol. 2009;18(3):242–6.PubMedCrossRef
Metadata
Title
Does Robotic Prostatectomy Meet Its Promise in the Management of Prostate Cancer?
Authors
Kuo-How Huang
Stacey C. Carter
Jim C. Hu
Publication date
01-06-2013
Publisher
Current Science Inc.
Published in
Current Urology Reports / Issue 3/2013
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-013-0327-8

Other articles of this Issue 3/2013

Current Urology Reports 3/2013 Go to the issue

Female Urology (H Goldman, Section Editor)

Practical Use of the New American Urological Association Adult Urodynamics Guidelines

Prostate Cancer (D Parekh, Section Editor)

Management of Castrate Resistant Prostate Cancer—Recent Advances and Optimal Sequence of Treatments

Prostate Cancer (D Parekh, Section Editor)

MRI-Guided Biopsy for Prostate Cancer Detection: A Systematic Review of Current Clinical Results

Prostate Cancer (D Parekh, Section Editor)

Risk-Based Prostate Cancer Screening: Who and How?

Female Urology (H Goldman, Section Editor)

Advances in Minimally Invasive Repair of Vesicovaginal Fistulas

Female Urology (H Goldman, Section Editor)

Are Recurrence Rates for “Traditional” Transvaginal Prolapse Repairs Really that High? What Does the Evidence Show?